<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940128-1-00086</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=81 g=1 f=1 --> 1. Costs  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline --> FDA specifically requests comments on:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) The expected cost to retrofit plants as necessary for  <!-- PJG 0012 frnewline --> the proper operation of HACCP controls (e.g., enhance  <!-- PJG 0012 frnewline --> refrigerator capacity, water supply changes, etc.).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) The cost of taking corrective actions to respond to  <!-- PJG 0012 frnewline --> critical limit deviations on an annual basis. FDA has estimated  <!-- PJG 0012 frnewline --> an average of $1,000 per firm to take such actions as discarding  <!-- PJG 0012 frnewline --> product, buying new equipment, and changing the processing  <!-- PJG 0012 frnewline --> practice.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) The cost of training employees. FDA has estimated that  <!-- PJG 0012 frnewline --> there will be a cost per plant of $900 to train an employee to  <!-- PJG 0012 frnewline --> manage HACCP. This will include the cost of training, travel  <!-- PJG 0012 frnewline --> expenses, and loss of several days of productivity for that  <!-- PJG 0012 frnewline --> employee. Not all of these costs may be borne by manufacturers,  <!-- PJG 0012 frnewline --> however, because some training may be sponsored by academia,  <!-- PJG 0012 frnewline --> trade associations, and others.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (4) The cost of ensuring that cooking and pasteurizing  <!-- PJG 0012 frnewline --> equipment and processes are achieving the desired safety results  <!-- PJG 0012 frnewline --> (i.e., destroying microbiological pathogens). This ensurance may  <!-- PJG 0012 frnewline --> be obtained by having equipment and processes that are equivalent  <!-- PJG 0012 frnewline --> to those found effective by a processing authority. FDA  <!-- PJG 0012 frnewline --> estimated that this would cost $1,000 per plant in the first year  <!-- PJG 0012 frnewline --> and, on average, half that amount in the following years as  <!-- PJG 0012 frnewline --> processors change their processes and equipment. This cost may be offset, however, by reliance on literature that contains the  <!-- PJG 0012 frnewline --> necessary information from a processing authority.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (5) The cost of temperature indicators and thermometers for  <!-- PJG 0012 frnewline --> plants who do not now have this equipment. FDA estimated that  <!-- PJG 0012 frnewline --> the cost would be $1,000 per plant, initially, with replacement  <!-- PJG 0012 frnewline --> as necessary.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (6) The cost of creating a HACCP plan from the guidance  <!-- PJG 0012 frnewline --> provided by FDA. FDA estimated that it will take processors with  <!-- PJG 0012 frnewline --> simpler processes 24 hours of managerial time to adapt the  <!-- PJG 0012 frnewline --> guidance into a HACCP plan. FDA estimated that it will take  <!-- PJG 0012 frnewline --> processors with more complex processes 72 hours of managerial  <!-- PJG 0012 frnewline --> time to adapt the guidance into a HACCP plan.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (7) FDA requests comment on the recordkeeping burden  <!-- PJG 0012 frnewline --> associated with the proposed sanitation requirements in &sect;123.10  <!-- PJG 0012 frnewline --> (b) and (c). If possible, such estimates should be provided in  <!-- PJG 0012 frnewline --> terms of hours spent and translated into dollars if staff  <!-- PJG 0012 frnewline --> compensation rates are known.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> In addition, FDA was unable to provide cost estimates of the  <!-- PJG 0012 frnewline --> following provisions and requests specific comments on these  <!-- PJG 0012 frnewline --> areas:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) Section 123.10(a)(7), prevention of cross-contamination  <!-- PJG 0012 frnewline --> by the separation of food-contact surfaces;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) Section 123.10(a)(14), storage at 40  <!-- PJG 0040 degreeslatlong --> &cir;F or below;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) Appendix A.6., cooling after cooking;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (4) Appendix B., scombroid toxin forming species;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (5) Appendix 1., specifically, the guidance on smoked and  <!-- PJG 0012 frnewline --> smoke-flavored fishery products;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (6) Increased short-term recall potential, if any, due to  <!-- PJG 0012 frnewline --> heightened industry awareness;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (7) Increasing time spent escorting Federal inspectors,  <!-- PJG 0012 frnewline --> particularly in the initial phases;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (8) The cost of restricting catch in certain areas and  <!-- PJG 0012 frnewline --> seasons if processors find it necessary.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 2. Benefits  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline --> (1) FDA is reprinting two tables from the PRIA and requests  <!-- PJG 0012 frnewline --> comments on both the baseline number of illnesses due to seafood  <!-- PJG 0012 frnewline --> and the likelihood that HACCP for processors will reduce those  <!-- PJG 0012 frnewline --> illnesses. The baseline number of illnesses reflects an estimate  <!-- PJG 0012 frnewline --> of all cases (from any source, including recreational harvest,  <!-- PJG 0012 frnewline --> retail, and consumer mishandling). FDA considers the estimates  <!-- PJG 0012 frnewline --> in both tables as preliminary estimates. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            